Global Diagnostic Radiopharmaceuticals Market Research Report 2024(Status and Outlook)
Report Overview:
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
The Global Diagnostic Radiopharmaceuticals Market Size was estimated at USD 2944.59 million in 2023 and is projected to reach USD 4394.31 million by 2029, exhibiting a CAGR of 6.90% during the forecast period.
This report provides a deep insight into the global Diagnostic Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Diagnostic Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Diagnostic Radiopharmaceuticals market in any manner.
Global Diagnostic Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Market Segmentation (by Type)
Technetium 99
Fluorine 18
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diagnostic Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
The Global Diagnostic Radiopharmaceuticals Market Size was estimated at USD 2944.59 million in 2023 and is projected to reach USD 4394.31 million by 2029, exhibiting a CAGR of 6.90% during the forecast period.
This report provides a deep insight into the global Diagnostic Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Diagnostic Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Diagnostic Radiopharmaceuticals market in any manner.
Global Diagnostic Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Market Segmentation (by Type)
Technetium 99
Fluorine 18
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Diagnostic Radiopharmaceuticals Market
- Overview of the regional outlook of the Diagnostic Radiopharmaceuticals Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diagnostic Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Diagnostic Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Diagnostic Radiopharmaceuticals Segment by Type
1.2.2 Diagnostic Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (2019-2024)
3.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.3 Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Diagnostic Radiopharmaceuticals Sales Sites, Area Served, Product Type
3.6 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
3.6.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DIAGNOSTIC RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DIAGNOSTIC RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2024)
6.3 Global Diagnostic Radiopharmaceuticals Market Size Market Share by Type (2019-2024)
6.4 Global Diagnostic Radiopharmaceuticals Price by Type (2019-2024)
7 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diagnostic Radiopharmaceuticals Market Sales by Application (2019-2024)
7.3 Global Diagnostic Radiopharmaceuticals Market Size (M USD) by Application (2019-2024)
7.4 Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2019-2024)
8 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY REGION
8.1 Global Diagnostic Radiopharmaceuticals Sales by Region
8.1.1 Global Diagnostic Radiopharmaceuticals Sales by Region
8.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America Diagnostic Radiopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Diagnostic Radiopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cardinal Health
9.1.1 Cardinal Health Diagnostic Radiopharmaceuticals Basic Information
9.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Overview
9.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Product Market Performance
9.1.4 Cardinal Health Business Overview
9.1.5 Cardinal Health Diagnostic Radiopharmaceuticals SWOT Analysis
9.1.6 Cardinal Health Recent Developments
9.2 GE Healthcare
9.2.1 GE Healthcare Diagnostic Radiopharmaceuticals Basic Information
9.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Overview
9.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Product Market Performance
9.2.4 GE Healthcare Business Overview
9.2.5 GE Healthcare Diagnostic Radiopharmaceuticals SWOT Analysis
9.2.6 GE Healthcare Recent Developments
9.3 Curium Pharma
9.3.1 Curium Pharma Diagnostic Radiopharmaceuticals Basic Information
9.3.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Overview
9.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Product Market Performance
9.3.4 Curium Pharma Diagnostic Radiopharmaceuticals SWOT Analysis
9.3.5 Curium Pharma Business Overview
9.3.6 Curium Pharma Recent Developments
9.4 Jubilant Pharma
9.4.1 Jubilant Pharma Diagnostic Radiopharmaceuticals Basic Information
9.4.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Overview
9.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Market Performance
9.4.4 Jubilant Pharma Business Overview
9.4.5 Jubilant Pharma Recent Developments
9.5 Bracco Imaging
9.5.1 Bracco Imaging Diagnostic Radiopharmaceuticals Basic Information
9.5.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Overview
9.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Product Market Performance
9.5.4 Bracco Imaging Business Overview
9.5.5 Bracco Imaging Recent Developments
9.6 Advanced Accelerator Applications
9.6.1 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Basic Information
9.6.2 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Overview
9.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Market Performance
9.6.4 Advanced Accelerator Applications Business Overview
9.6.5 Advanced Accelerator Applications Recent Developments
9.7 SIEMENS
9.7.1 SIEMENS Diagnostic Radiopharmaceuticals Basic Information
9.7.2 SIEMENS Diagnostic Radiopharmaceuticals Product Overview
9.7.3 SIEMENS Diagnostic Radiopharmaceuticals Product Market Performance
9.7.4 SIEMENS Business Overview
9.7.5 SIEMENS Recent Developments
9.8 China Isotope and Radiation
9.8.1 China Isotope and Radiation Diagnostic Radiopharmaceuticals Basic Information
9.8.2 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Overview
9.8.3 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Market Performance
9.8.4 China Isotope and Radiation Business Overview
9.8.5 China Isotope and Radiation Recent Developments
9.9 Dongcheng Pharmaceutical Group
9.9.1 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Basic Information
9.9.2 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Overview
9.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Market Performance
9.9.4 Dongcheng Pharmaceutical Group Business Overview
9.9.5 Dongcheng Pharmaceutical Group Recent Developments
9.10 Lantheus
9.10.1 Lantheus Diagnostic Radiopharmaceuticals Basic Information
9.10.2 Lantheus Diagnostic Radiopharmaceuticals Product Overview
9.10.3 Lantheus Diagnostic Radiopharmaceuticals Product Market Performance
9.10.4 Lantheus Business Overview
9.10.5 Lantheus Recent Developments
9.11 Eli Lilly
9.11.1 Eli Lilly Diagnostic Radiopharmaceuticals Basic Information
9.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Overview
9.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Product Market Performance
9.11.4 Eli Lilly Business Overview
9.11.5 Eli Lilly Recent Developments
10 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
10.1 Global Diagnostic Radiopharmaceuticals Market Size Forecast
10.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country
10.2.3 Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Region
10.2.4 South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Diagnostic Radiopharmaceuticals by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Diagnostic Radiopharmaceuticals Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2025-2030)
11.1.2 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Diagnostic Radiopharmaceuticals by Type (2025-2030)
11.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Application (2025-2030)
11.2.1 Global Diagnostic Radiopharmaceuticals Sales (Kilotons) Forecast by Application
11.2.2 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Diagnostic Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Diagnostic Radiopharmaceuticals Segment by Type
1.2.2 Diagnostic Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (2019-2024)
3.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.3 Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Diagnostic Radiopharmaceuticals Sales Sites, Area Served, Product Type
3.6 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
3.6.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DIAGNOSTIC RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DIAGNOSTIC RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2024)
6.3 Global Diagnostic Radiopharmaceuticals Market Size Market Share by Type (2019-2024)
6.4 Global Diagnostic Radiopharmaceuticals Price by Type (2019-2024)
7 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diagnostic Radiopharmaceuticals Market Sales by Application (2019-2024)
7.3 Global Diagnostic Radiopharmaceuticals Market Size (M USD) by Application (2019-2024)
7.4 Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2019-2024)
8 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY REGION
8.1 Global Diagnostic Radiopharmaceuticals Sales by Region
8.1.1 Global Diagnostic Radiopharmaceuticals Sales by Region
8.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America Diagnostic Radiopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Diagnostic Radiopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cardinal Health
9.1.1 Cardinal Health Diagnostic Radiopharmaceuticals Basic Information
9.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Overview
9.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Product Market Performance
9.1.4 Cardinal Health Business Overview
9.1.5 Cardinal Health Diagnostic Radiopharmaceuticals SWOT Analysis
9.1.6 Cardinal Health Recent Developments
9.2 GE Healthcare
9.2.1 GE Healthcare Diagnostic Radiopharmaceuticals Basic Information
9.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Overview
9.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Product Market Performance
9.2.4 GE Healthcare Business Overview
9.2.5 GE Healthcare Diagnostic Radiopharmaceuticals SWOT Analysis
9.2.6 GE Healthcare Recent Developments
9.3 Curium Pharma
9.3.1 Curium Pharma Diagnostic Radiopharmaceuticals Basic Information
9.3.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Overview
9.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Product Market Performance
9.3.4 Curium Pharma Diagnostic Radiopharmaceuticals SWOT Analysis
9.3.5 Curium Pharma Business Overview
9.3.6 Curium Pharma Recent Developments
9.4 Jubilant Pharma
9.4.1 Jubilant Pharma Diagnostic Radiopharmaceuticals Basic Information
9.4.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Overview
9.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Market Performance
9.4.4 Jubilant Pharma Business Overview
9.4.5 Jubilant Pharma Recent Developments
9.5 Bracco Imaging
9.5.1 Bracco Imaging Diagnostic Radiopharmaceuticals Basic Information
9.5.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Overview
9.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Product Market Performance
9.5.4 Bracco Imaging Business Overview
9.5.5 Bracco Imaging Recent Developments
9.6 Advanced Accelerator Applications
9.6.1 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Basic Information
9.6.2 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Overview
9.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Market Performance
9.6.4 Advanced Accelerator Applications Business Overview
9.6.5 Advanced Accelerator Applications Recent Developments
9.7 SIEMENS
9.7.1 SIEMENS Diagnostic Radiopharmaceuticals Basic Information
9.7.2 SIEMENS Diagnostic Radiopharmaceuticals Product Overview
9.7.3 SIEMENS Diagnostic Radiopharmaceuticals Product Market Performance
9.7.4 SIEMENS Business Overview
9.7.5 SIEMENS Recent Developments
9.8 China Isotope and Radiation
9.8.1 China Isotope and Radiation Diagnostic Radiopharmaceuticals Basic Information
9.8.2 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Overview
9.8.3 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Market Performance
9.8.4 China Isotope and Radiation Business Overview
9.8.5 China Isotope and Radiation Recent Developments
9.9 Dongcheng Pharmaceutical Group
9.9.1 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Basic Information
9.9.2 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Overview
9.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Market Performance
9.9.4 Dongcheng Pharmaceutical Group Business Overview
9.9.5 Dongcheng Pharmaceutical Group Recent Developments
9.10 Lantheus
9.10.1 Lantheus Diagnostic Radiopharmaceuticals Basic Information
9.10.2 Lantheus Diagnostic Radiopharmaceuticals Product Overview
9.10.3 Lantheus Diagnostic Radiopharmaceuticals Product Market Performance
9.10.4 Lantheus Business Overview
9.10.5 Lantheus Recent Developments
9.11 Eli Lilly
9.11.1 Eli Lilly Diagnostic Radiopharmaceuticals Basic Information
9.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Overview
9.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Product Market Performance
9.11.4 Eli Lilly Business Overview
9.11.5 Eli Lilly Recent Developments
10 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
10.1 Global Diagnostic Radiopharmaceuticals Market Size Forecast
10.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country
10.2.3 Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Region
10.2.4 South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Diagnostic Radiopharmaceuticals by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Diagnostic Radiopharmaceuticals Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2025-2030)
11.1.2 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Diagnostic Radiopharmaceuticals by Type (2025-2030)
11.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Application (2025-2030)
11.2.1 Global Diagnostic Radiopharmaceuticals Sales (Kilotons) Forecast by Application
11.2.2 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Diagnostic Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2022)
Table 10. Global Market Diagnostic Radiopharmaceuticals Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Diagnostic Radiopharmaceuticals Sales Sites and Area Served
Table 12. Manufacturers Diagnostic Radiopharmaceuticals Product Type
Table 13. Global Diagnostic Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Diagnostic Radiopharmaceuticals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Diagnostic Radiopharmaceuticals Market Challenges
Table 22. Global Diagnostic Radiopharmaceuticals Sales by Type (Kilotons)
Table 23. Global Diagnostic Radiopharmaceuticals Market Size by Type (M USD)
Table 24. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) by Type (2019-2024)
Table 25. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Table 26. Global Diagnostic Radiopharmaceuticals Market Size (M USD) by Type (2019-2024)
Table 27. Global Diagnostic Radiopharmaceuticals Market Size Share by Type (2019-2024)
Table 28. Global Diagnostic Radiopharmaceuticals Price (USD/Ton) by Type (2019-2024)
Table 29. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) by Application
Table 30. Global Diagnostic Radiopharmaceuticals Market Size by Application
Table 31. Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Table 33. Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (M USD)
Table 34. Global Diagnostic Radiopharmaceuticals Market Share by Application (2019-2024)
Table 35. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2019-2024)
Table 36. Global Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Table 38. North America Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 43. Cardinal Health Diagnostic Radiopharmaceuticals Basic Information
Table 44. Cardinal Health Diagnostic Radiopharmaceuticals Product Overview
Table 45. Cardinal Health Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Cardinal Health Business Overview
Table 47. Cardinal Health Diagnostic Radiopharmaceuticals SWOT Analysis
Table 48. Cardinal Health Recent Developments
Table 49. GE Healthcare Diagnostic Radiopharmaceuticals Basic Information
Table 50. GE Healthcare Diagnostic Radiopharmaceuticals Product Overview
Table 51. GE Healthcare Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Diagnostic Radiopharmaceuticals SWOT Analysis
Table 54. GE Healthcare Recent Developments
Table 55. Curium Pharma Diagnostic Radiopharmaceuticals Basic Information
Table 56. Curium Pharma Diagnostic Radiopharmaceuticals Product Overview
Table 57. Curium Pharma Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Curium Pharma Diagnostic Radiopharmaceuticals SWOT Analysis
Table 59. Curium Pharma Business Overview
Table 60. Curium Pharma Recent Developments
Table 61. Jubilant Pharma Diagnostic Radiopharmaceuticals Basic Information
Table 62. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Overview
Table 63. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Jubilant Pharma Business Overview
Table 65. Jubilant Pharma Recent Developments
Table 66. Bracco Imaging Diagnostic Radiopharmaceuticals Basic Information
Table 67. Bracco Imaging Diagnostic Radiopharmaceuticals Product Overview
Table 68. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Bracco Imaging Business Overview
Table 70. Bracco Imaging Recent Developments
Table 71. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Basic Information
Table 72. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Overview
Table 73. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Advanced Accelerator Applications Business Overview
Table 75. Advanced Accelerator Applications Recent Developments
Table 76. SIEMENS Diagnostic Radiopharmaceuticals Basic Information
Table 77. SIEMENS Diagnostic Radiopharmaceuticals Product Overview
Table 78. SIEMENS Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. SIEMENS Business Overview
Table 80. SIEMENS Recent Developments
Table 81. China Isotope and Radiation Diagnostic Radiopharmaceuticals Basic Information
Table 82. China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Overview
Table 83. China Isotope and Radiation Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. China Isotope and Radiation Business Overview
Table 85. China Isotope and Radiation Recent Developments
Table 86. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Basic Information
Table 87. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Overview
Table 88. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Dongcheng Pharmaceutical Group Business Overview
Table 90. Dongcheng Pharmaceutical Group Recent Developments
Table 91. Lantheus Diagnostic Radiopharmaceuticals Basic Information
Table 92. Lantheus Diagnostic Radiopharmaceuticals Product Overview
Table 93. Lantheus Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Lantheus Business Overview
Table 95. Lantheus Recent Developments
Table 96. Eli Lilly Diagnostic Radiopharmaceuticals Basic Information
Table 97. Eli Lilly Diagnostic Radiopharmaceuticals Product Overview
Table 98. Eli Lilly Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Recent Developments
Table 101. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Diagnostic Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Diagnostic Radiopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Diagnostic Radiopharmaceuticals Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Diagnostic Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2022)
Table 10. Global Market Diagnostic Radiopharmaceuticals Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Diagnostic Radiopharmaceuticals Sales Sites and Area Served
Table 12. Manufacturers Diagnostic Radiopharmaceuticals Product Type
Table 13. Global Diagnostic Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Diagnostic Radiopharmaceuticals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Diagnostic Radiopharmaceuticals Market Challenges
Table 22. Global Diagnostic Radiopharmaceuticals Sales by Type (Kilotons)
Table 23. Global Diagnostic Radiopharmaceuticals Market Size by Type (M USD)
Table 24. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) by Type (2019-2024)
Table 25. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2024)
Table 26. Global Diagnostic Radiopharmaceuticals Market Size (M USD) by Type (2019-2024)
Table 27. Global Diagnostic Radiopharmaceuticals Market Size Share by Type (2019-2024)
Table 28. Global Diagnostic Radiopharmaceuticals Price (USD/Ton) by Type (2019-2024)
Table 29. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) by Application
Table 30. Global Diagnostic Radiopharmaceuticals Market Size by Application
Table 31. Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Table 33. Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2024) & (M USD)
Table 34. Global Diagnostic Radiopharmaceuticals Market Share by Application (2019-2024)
Table 35. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2019-2024)
Table 36. Global Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Table 38. North America Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Diagnostic Radiopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 43. Cardinal Health Diagnostic Radiopharmaceuticals Basic Information
Table 44. Cardinal Health Diagnostic Radiopharmaceuticals Product Overview
Table 45. Cardinal Health Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Cardinal Health Business Overview
Table 47. Cardinal Health Diagnostic Radiopharmaceuticals SWOT Analysis
Table 48. Cardinal Health Recent Developments
Table 49. GE Healthcare Diagnostic Radiopharmaceuticals Basic Information
Table 50. GE Healthcare Diagnostic Radiopharmaceuticals Product Overview
Table 51. GE Healthcare Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Diagnostic Radiopharmaceuticals SWOT Analysis
Table 54. GE Healthcare Recent Developments
Table 55. Curium Pharma Diagnostic Radiopharmaceuticals Basic Information
Table 56. Curium Pharma Diagnostic Radiopharmaceuticals Product Overview
Table 57. Curium Pharma Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Curium Pharma Diagnostic Radiopharmaceuticals SWOT Analysis
Table 59. Curium Pharma Business Overview
Table 60. Curium Pharma Recent Developments
Table 61. Jubilant Pharma Diagnostic Radiopharmaceuticals Basic Information
Table 62. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Overview
Table 63. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Jubilant Pharma Business Overview
Table 65. Jubilant Pharma Recent Developments
Table 66. Bracco Imaging Diagnostic Radiopharmaceuticals Basic Information
Table 67. Bracco Imaging Diagnostic Radiopharmaceuticals Product Overview
Table 68. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Bracco Imaging Business Overview
Table 70. Bracco Imaging Recent Developments
Table 71. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Basic Information
Table 72. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Overview
Table 73. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Advanced Accelerator Applications Business Overview
Table 75. Advanced Accelerator Applications Recent Developments
Table 76. SIEMENS Diagnostic Radiopharmaceuticals Basic Information
Table 77. SIEMENS Diagnostic Radiopharmaceuticals Product Overview
Table 78. SIEMENS Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. SIEMENS Business Overview
Table 80. SIEMENS Recent Developments
Table 81. China Isotope and Radiation Diagnostic Radiopharmaceuticals Basic Information
Table 82. China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Overview
Table 83. China Isotope and Radiation Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. China Isotope and Radiation Business Overview
Table 85. China Isotope and Radiation Recent Developments
Table 86. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Basic Information
Table 87. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Overview
Table 88. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Dongcheng Pharmaceutical Group Business Overview
Table 90. Dongcheng Pharmaceutical Group Recent Developments
Table 91. Lantheus Diagnostic Radiopharmaceuticals Basic Information
Table 92. Lantheus Diagnostic Radiopharmaceuticals Product Overview
Table 93. Lantheus Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Lantheus Business Overview
Table 95. Lantheus Recent Developments
Table 96. Eli Lilly Diagnostic Radiopharmaceuticals Basic Information
Table 97. Eli Lilly Diagnostic Radiopharmaceuticals Product Overview
Table 98. Eli Lilly Diagnostic Radiopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Recent Developments
Table 101. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Diagnostic Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Diagnostic Radiopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Diagnostic Radiopharmaceuticals Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Diagnostic Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Diagnostic Radiopharmaceuticals Market Size (M USD), 2019-2030
Figure 5. Global Diagnostic Radiopharmaceuticals Market Size (M USD) (2019-2030)
Figure 6. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Diagnostic Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Diagnostic Radiopharmaceuticals Sales Share by Manufacturers in 2023
Figure 12. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers in 2023
Figure 13. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Diagnostic Radiopharmaceuticals Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Diagnostic Radiopharmaceuticals Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Diagnostic Radiopharmaceuticals Market Share by Type
Figure 18. Sales Market Share of Diagnostic Radiopharmaceuticals by Type (2019-2024)
Figure 19. Sales Market Share of Diagnostic Radiopharmaceuticals by Type in 2023
Figure 20. Market Size Share of Diagnostic Radiopharmaceuticals by Type (2019-2024)
Figure 21. Market Size Market Share of Diagnostic Radiopharmaceuticals by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Diagnostic Radiopharmaceuticals Market Share by Application
Figure 24. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 25. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2023
Figure 26. Global Diagnostic Radiopharmaceuticals Market Share by Application (2019-2024)
Figure 27. Global Diagnostic Radiopharmaceuticals Market Share by Application in 2023
Figure 28. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2019-2024)
Figure 29. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Figure 30. North America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 32. U.S. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Diagnostic Radiopharmaceuticals Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Diagnostic Radiopharmaceuticals Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 37. Germany Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Diagnostic Radiopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2023
Figure 44. China Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Diagnostic Radiopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 50. South America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 51. Brazil Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Diagnostic Radiopharmaceuticals Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Type (2025-2030)
Figure 65. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2025-2030)
Figure 66. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Diagnostic Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Diagnostic Radiopharmaceuticals Market Size (M USD), 2019-2030
Figure 5. Global Diagnostic Radiopharmaceuticals Market Size (M USD) (2019-2030)
Figure 6. Global Diagnostic Radiopharmaceuticals Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Diagnostic Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Diagnostic Radiopharmaceuticals Sales Share by Manufacturers in 2023
Figure 12. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers in 2023
Figure 13. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Diagnostic Radiopharmaceuticals Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Diagnostic Radiopharmaceuticals Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Diagnostic Radiopharmaceuticals Market Share by Type
Figure 18. Sales Market Share of Diagnostic Radiopharmaceuticals by Type (2019-2024)
Figure 19. Sales Market Share of Diagnostic Radiopharmaceuticals by Type in 2023
Figure 20. Market Size Share of Diagnostic Radiopharmaceuticals by Type (2019-2024)
Figure 21. Market Size Market Share of Diagnostic Radiopharmaceuticals by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Diagnostic Radiopharmaceuticals Market Share by Application
Figure 24. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 25. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2023
Figure 26. Global Diagnostic Radiopharmaceuticals Market Share by Application (2019-2024)
Figure 27. Global Diagnostic Radiopharmaceuticals Market Share by Application in 2023
Figure 28. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2019-2024)
Figure 29. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2019-2024)
Figure 30. North America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 32. U.S. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Diagnostic Radiopharmaceuticals Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Diagnostic Radiopharmaceuticals Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 37. Germany Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Diagnostic Radiopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2023
Figure 44. China Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Diagnostic Radiopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 50. South America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2023
Figure 51. Brazil Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Diagnostic Radiopharmaceuticals Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Type (2025-2030)
Figure 65. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2025-2030)
Figure 66. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Application (2025-2030)
